Medicare Enrolled
Dr. Rocio Harbison, MD
Endocrinology · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Harbison from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Harbison?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Harbison
Dr. Rocio Harbison is an endocrinology specialist in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Harbison performed 2,502 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Harbison received a total of $1,001,927 from 59 pharmaceutical and/or device companies across 1605 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Harbison is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 18% volume in TX
$1,001,927 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,502
Medicare services
Top 18% in TX for endocrinology
Not available
Unique patients (not deduplicated)
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,500 | $18 | $40 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
400 | $94 | $221 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
144 | $9 | $50 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
125 | $26 | $91 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
74 | $4 | $30 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
61 | $135 | $297 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
52 | $13 | $50 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
30 | $11 | $53 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $132 | $337 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
24 | $93 | $283 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
22 | $93 | $290 |
| Autonomic nervous system testing with heart rate response to deep breathing This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing. |
21 | $66 | $176 |
| New patient office visit, complex (60-74 min) | 21 | $161 | $424 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$1,001,927
Total received (2018-2024)
Avg $143,132/year across 7 years
Top 2% in TX for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
1,605
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$150,702
2023
$118,726
2022
$200,131
2021
$116,987
2020
$138,510
2019
$125,741
2018
$151,129
Payments by company (2024)
Corcept Therapeutics
$89,631
Lilly USA, LLC
$46,727
Novo Nordisk Inc
$7,396
Medtronic, Inc.
$3,404
Dexcom, Inc.
$1,579
ModernaTX, Inc.
$1,553
BETA BIONICS, INC.
$144
Xeris Pharmaceuticals, Inc.
$89
ABBVIE INC.
$44
Astellas Pharma US Inc
$29
Alexion Pharmaceuticals, Inc.
$25
Radius Health, Inc.
$24
Amgen Inc.
$22
Abbott Laboratories
$19
AstraZeneca Pharmaceuticals LP
$17
Top 3 companies account for 95.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$350,839
Lilly USA, LLC
$184,671
Corcept Therapeutics
$161,553
AstraZeneca Pharmaceuticals LP
$102,513
Medtronic, Inc.
$47,814
Medtronic MiniMed, Inc.
$43,267
Dexcom, Inc.
$32,666
Tandem Diabetes Care, Inc.
$28,552
SANOFI-AVENTIS U.S. LLC
$21,784
AbbVie Inc.
$9,246
Companion Medical, Inc.
$4,677
ABBVIE INC.
$2,731
DEXCOM, INC.
$2,393
IBSA Pharma Inc.
$2,057
AbbVie, Inc.
$2,022
ModernaTX, Inc.
$1,553
Janssen Pharmaceuticals, Inc
$598
Bigfoot Biomedical Inc
$360
Amgen Inc.
$359
Valeritas, Inc.
$232
Boehringer Ingelheim Pharmaceuticals, Inc.
$227
Insulet Corporation
$160
BETA BIONICS, INC.
$144
Xeris Pharmaceuticals, Inc.
$137
CeQur Corporation
$116
Abbott Laboratories
$109
Mannkind Corporation
$92
Shire North American Group Inc
$90
Amarin Pharma Inc.
$79
KVK-Tech, Inc.
$78
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$77
Astellas Pharma US Inc
$62
Senseonics, Incorporated
$60
Synergy Pharmaceuticals Inc
$42
Zealand Pharma US, Inc.
$40
Alexion Pharmaceuticals, Inc.
$39
Radius Health, Inc.
$36
Novartis Pharmaceuticals Corporation
$34
Intuity Medical Inc
$34
Kowa Pharmaceuticals America, Inc.
$30
Bayer HealthCare Pharmaceuticals Inc.
$29
VistaPharm, Inc.
$27
GRT US Holding, Inc.
$27
Amneal Pharmaceuticals LLC
$27
Merck Sharp & Dohme Corporation
$25
Esperion Therapeutics, Inc.
$20
Strongbridge US INC.
$19
RECORDATI_RARE_DISEASES_INC.
$19
Supernus Pharmaceuticals, Inc.
$18
VIVUS LLC
$17
TherapeuticsMD, Inc.
$16
LifeScan, Inc.
$16
Regeneron Healthcare Solutions, Inc.
$15
VIVUS, Inc.
$15
Eisai Inc.
$15
Vertical Pharmaceuticals, LLC
$14
Antares Pharma, Inc.
$14
AMAG Pharmaceuticals, Inc.
$12
Currax Pharmaceuticals LLC
$10
Top 3 companies account for 69.6% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BYDUREON · CONTRAVE · CYCLOSET · CeQur Simplicity · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · DIVIGEL · Dayvigo · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · Eversense · FARXIGA · FREESTYLE LIBRE 3 · FreeStyle Libre · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · IMVEXXY · INPEN SMART INSULIN DELIVERY SYSTEM · INTRAROSA · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LANTUS · LEQVIO · LICART · LINZESS · Levemir · Livalo · MACRILEN · MINIMED 770G · MINIMED 780G · MOUNJARO · Minimed 530G · Minimed 670G System · Myrbetriq · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NO PRODUCT DISCUSSED · NOCDURNA · NovoLog · Omnipod · OneTouch · Ozempic · PRALUENT · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · Qsymia · Qutenza · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · STRENSIQ · SYNTHROID · Saxenda · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULANCE · TRULICITY · Thyquidity · Tirosint · Tresiba · Trulance · Tymlos · UBRELVY · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VIBERZI · Vascepa · Veozah · Victoza · Wegovy · XIFAXAN · XYOSTED · Xultophy 100/3.6 · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
142
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
WOMANS HOSPITAL OF TEXAS,THE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Harbison is a clinical cardiology specialist, with above-average Medicare volume (top 18% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Harbison experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Harbison performed 1,500 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Harbison receive payments from pharmaceutical companies?
Yes. Dr. Harbison received a total of $1,001,927 from 59 companies across 1,605 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Harbison's costs compare to other endocrinologists in Houston?
Dr. Harbison's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Harbison) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Houston
Browse endocrinologists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in TX
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in TX
Which TX endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Corcept Therapeutics Payments to Doctors
See all physicians who received payments from Corcept Therapeutics.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology